Bio-Rad Laboratories Gross Profit 2010-2024 | BIO
Bio-Rad Laboratories annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Bio-Rad Laboratories gross profit for the quarter ending March 31, 2024 was $0.326B, a 10.06% decline year-over-year.
- Bio-Rad Laboratories gross profit for the twelve months ending March 31, 2024 was $1.390B, a 8.95% decline year-over-year.
- Bio-Rad Laboratories annual gross profit for 2023 was $1.427B, a 8.96% decline from 2022.
- Bio-Rad Laboratories annual gross profit for 2022 was $1.567B, a 4.32% decline from 2021.
- Bio-Rad Laboratories annual gross profit for 2021 was $1.638B, a 13.92% increase from 2020.
| Bio-Rad Laboratories Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $1,427 |
| 2022 | $1,567 |
| 2021 | $1,638 |
| 2020 | $1,438 |
| 2019 | $1,257 |
| 2018 | $1,223 |
| 2017 | $1,188 |
| 2016 | $1,138 |
| 2015 | $1,122 |
| 2014 | $1,179 |
| 2013 | $1,178 |
| 2012 | $1,155 |
| 2011 | $1,179 |
| 2010 | $1,091 |
| 2009 | $1,000 |
| Bio-Rad Laboratories Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-03-31 | $326 |
| 2023-12-31 | $366 |
| 2023-09-30 | $336 |
| 2023-06-30 | $362 |
| 2023-03-31 | $362 |
| 2022-12-31 | $397 |
| 2022-09-30 | $373 |
| 2022-06-30 | $395 |
| 2022-03-31 | $403 |
| 2021-12-31 | $398 |
| 2021-09-30 | $437 |
| 2021-06-30 | $402 |
| 2021-03-31 | $401 |
| 2020-12-31 | $460 |
| 2020-09-30 | $367 |
| 2020-06-30 | $293 |
| 2020-03-31 | $317 |
| 2019-12-31 | $330 |
| 2019-09-30 | $307 |
| 2019-06-30 | $308 |
| 2019-03-31 | $312 |
| 2018-12-31 | $333 |
| 2018-09-30 | $287 |
| 2018-06-30 | $302 |
| 2018-03-31 | $302 |
| 2017-12-31 | $345 |
| 2017-09-30 | $299 |
| 2017-06-30 | $273 |
| 2017-03-31 | $270 |
| 2016-12-31 | $315 |
| 2016-09-30 | $279 |
| 2016-06-30 | $280 |
| 2016-03-31 | $264 |
| 2015-12-31 | $309 |
| 2015-09-30 | $263 |
| 2015-06-30 | $280 |
| 2015-03-31 | $270 |
| 2014-12-31 | $317 |
| 2014-09-30 | $289 |
| 2014-06-30 | $297 |
| 2014-03-31 | $275 |
| 2013-12-31 | $323 |
| 2013-09-30 | $284 |
| 2013-06-30 | $300 |
| 2013-03-31 | $271 |
| 2012-12-31 | $315 |
| 2012-09-30 | $274 |
| 2012-06-30 | $288 |
| 2012-03-31 | $279 |
| 2011-12-31 | $312 |
| 2011-09-30 | $296 |
| 2011-06-30 | $293 |
| 2011-03-31 | $278 |
| 2010-12-31 | $300 |
| 2010-09-30 | $266 |
| 2010-06-30 | $268 |
| 2010-03-31 | $257 |
| 2009-12-31 | $268 |
| 2009-09-30 | $261 |
| 2009-06-30 | $242 |
| 2009-03-31 | $229 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $7.790B | $2.671B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $180.765B | 23.67 |
| Stryker (SYK) | United States | $129.618B | 31.05 |
| Boston Scientific (BSX) | United States | $112.981B | 35.99 |
| Medtronic (MDT) | Ireland | $100.927B | 15.11 |
| EssilorLuxottica (ESLOY) | France | $99.128B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.585B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.716B | 27.53 |
| ResMed (RMD) | United States | $28.121B | 26.40 |
| Terumo (TRUMY) | Japan | $24.403B | 34.46 |
| Koninklijke Philips (PHG) | Netherlands | $22.841B | 18.13 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.328B | 14.26 |
| Baxter (BAX) | United States | $17.045B | 12.12 |
| Insulet (PODD) | United States | $14.134B | 62.67 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.833B | 0.00 |
| Demant (WILYY) | Denmark | $9.370B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.453B | 35.06 |
| Lantheus Holdings (LNTH) | United States | $5.565B | 13.87 |
| GN Store Nord (GNNDY) | Denmark | $4.222B | 23.71 |
| Haemonetics (HAE) | United States | $4.215B | 20.79 |
| Perrigo (PRGO) | Ireland | $3.501B | 10.61 |
| Prestige Consumer Healthcare (PBH) | United States | $3.437B | 16.35 |
| Neogen (NEOG) | United States | $3.386B | 32.56 |
| ICU Medical (ICUI) | United States | $2.893B | 25.54 |
| Envista Holdings (NVST) | United States | $2.858B | 11.79 |
| TG Therapeutics (TGTX) | United States | $2.749B | 77.35 |
| Green Thumb Industries (GTBIF) | United States | $2.552B | 49.96 |
| Agios Pharmaceuticals (AGIO) | United States | $2.448B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.225B | 12.35 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 54.13 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.804B | 0.00 |
| Warby Parker (WRBY) | United States | $1.592B | 0.00 |
| InMode (INMD) | Israel | $1.532B | 8.14 |
| AdaptHealth (AHCO) | United States | $1.332B | 9.90 |
| Verano Holdings (VRNOF) | United States | $1.246B | 0.00 |
| AtriCure (ATRC) | United States | $1.084B | 0.00 |
| Owens & Minor (OMI) | United States | $1.033B | 9.00 |
| National Vision Holdings (EYE) | United States | $1.028B | 32.72 |
| BioLife Solutions (BLFS) | United States | $0.987B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.679B | 14.46 |
| Evolus (EOLS) | United States | $0.679B | 0.00 |
| PetIQ (PETQ) | United States | $0.656B | 21.21 |
| VAREX IMAGING (VREX) | United States | $0.602B | 14.16 |
| Surmodics (SRDX) | United States | $0.599B | 37.54 |
| Quanterix (QTRX) | United States | $0.506B | 0.00 |
| ZimVie (ZIMV) | United States | $0.498B | 42.44 |
| Canopy Growth (CGC) | Canada | $0.491B | 0.00 |
| Valneva SE (VALN) | France | $0.488B | 0.00 |
| Biote (BTMD) | United States | $0.463B | 10.67 |
| Jin Medical (ZJYL) | China | $0.403B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.394B | 0.00 |
| Cerus (CERS) | United States | $0.325B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.315B | 10.14 |
| Zynex (ZYXI) | United States | $0.296B | 40.52 |
| MacroGenics (MGNX) | United States | $0.266B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 25.19 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.243B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 14.85 |
| Omeros (OMER) | United States | $0.235B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.233B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.153B | 21.76 |
| Capricor Therapeutics (CAPR) | United States | $0.153B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.137B | 0.00 |
| Veru (VERU) | United States | $0.123B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 10.26 |
| Brainsway (BWAY) | Israel | $0.101B | 0.00 |
| InterCure (INCR) | Israel | $0.092B | 15.46 |
| Cellectar Biosciences (CLRB) | United States | $0.090B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.073B | 4.75 |
| MariMed (MRMD) | United States | $0.069B | 0.00 |
| Safety Shot (SHOT) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.051B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.049B | 0.00 |
| Bright Green (BGXX) | United States | $0.048B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.041B | 14.90 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.021B | 0.00 |
| Agape ATP (ATPC) | $0.016B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |